Here's Bill Bonner's "4th and Final Prediction"
One of America's most successful entrepreneurs goes public with "4th and Final Prediction." His first three all came true—will this one too?
Click here for details...

TCBP Insider Trading (TC Biopharm)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $23,923.45
Insider Selling (Last 12 Months): $0.00

TC Biopharm Insider Trading History Chart

This chart shows the insider buying and selling history at TC Biopharm by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

TC Biopharm Share Price & Price History

Current Price: $0.41
Price Change: +0.30 (1.20%)
As of 08/12/2022 01:00 AM ET

This chart shows the closing price history over time for TCBP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
How Much Longer Will It Be Under $1?
The SEC and a group of high-powered lawyers have been hashing out a federally-regulated cryptocurrency.

Once ready, this crypto will become the 1st endorsed for use in the US.

I expect once the regulations are in place, this crypto's value will skyrocket.

Get into this crypto for under a dollar now.

TC Biopharm Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/24/2022Kenneth Edward RandallMajor ShareholderBuy20,803$1.15$23,923.45100,418View SEC Filing Icon  
See Full Table
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

SEC Filings (Institutional Ownership Changes) for TC Biopharm (NASDAQ:TCBP)

TC Biopharm Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/11/2022Warberg Asset Management LLC99,165$36K0.0%N/A0.261%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
TC Biopharm logo
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
Read More on TC Biopharm

Today's Range

Now: $0.41
Low: $0.40
High: $0.42

50 Day Range

MA: $0.38
Low: $0.34
High: $0.41

52 Week Range

Now: $0.41
Low: $0.33
High: $3.50


289,519 shs

Average Volume

716,905 shs

Market Capitalization

$15.54 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of TC Biopharm?

TC Biopharm's top insider investors include:
  1. Kenneth Edward Randall (Major Shareholder)
Learn More about top insider investors at TC Biopharm.

Who are the major institutional investors of TC Biopharm?

TC Biopharm's top institutional investors include:
  1. Warberg Asset Management LLC — 0.26%
Learn More about top institutional investors of TC Biopharm stock.

Which institutional investors are buying TC Biopharm stock?

Within the previous quarter, TCBP stock was purchased by institutional investors including:
  1. Warberg Asset Management LLC
Apple’s Next “Star Product” Could Replace The iPhone?
Apple's next "star product" could be its most profitable yet & may dominate a fast-growing new industry that Morgan Stanley projects will be worth a stunning $10 trillion!

The new “profit machine” could hand early investors a $190,717 payday.

How can you lock in your shot to 20X your money? 

See Here.